Richard Chin, President and CEO at Kindred Biosciences, Inc. (KIN), sold 40,000 shares at $13.51 ($540K) on 2018-08-01, disclosed to the SEC on 2018-08-03.
Open-market sale of $540k KIN by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KIN | SELL | 2021-06-17 | $367K | — | Filing → |
| KIN | SELL | 2019-01-04 | $423K | — | Filing → |
| KIN | SELL | 2018-12-04 | $531K | — | Filing → |